AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Biotechnology

Healthcare
$5.82 +2.48%

+$0.25 today

Market cap
$286.62M
Beta
2.62
P/E (TTM)
-7.1
EPS (TTM)
-$1.28
52W Low $8.75High $17.45

Volume 0.13M

Average 0.14M

AGMB Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB

Total Equity · Q3 FY2025 · quarter ended Sep 2025

Total equity of €146.93M in Q3 FY2025

Q3 FY2025 total equity was €146.93M.

Context

  • Total equity amounted to 88.7% of total assets at the end of Q3 FY2025.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2025
€146.93M— QoQ
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Total Equity history

Currency unavailable · from the balance sheet

No Total Equity data reported for this period type.

Total Equity vs competitors

How AGMB compares with its peers on the latest reported figures

  • Peers report in different currencies, so total equity is compared through growth and share of total assets rather than absolute size.
  • Total equity amounts to 88.7% of total assets for AGMB, versus a peer median of 76.5%.
AGMB Competitors
Total Equity for AGMB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALMSAlumis Inc. Common StockJun 2026$452.16M USD-6.8%—80.7%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€146.93M EUR——88.7%
ACRSAclaris Therapeutics, Inc.Mar 2026$143.65M USD-0.3%-19.5%72.3%
EQEquillium, Inc.Mar 2026$59.49M USD+462.4%-3.6%94.3%
ANABAnaptysBio, Inc.Mar 2026$12.75M USD-62.5%-47.8%3.9%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding AGMB) —-3.6%-19.5%76.5%

Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Intrinsic Alpha fair value

Locked

Current Price

$5.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.